Evonik Industries AG
E: healthcare@evonik.com
W: healthcare.evonik.com

 

Corporate Description

Evonik is one of the world leaders in specialty chemicals, with more than 36,000 employees across more than 100 countries and €14.4 billion in annual sales in 2017. The Business Line Health Care is a strategic partner to the world’s pharmaceutical companies, we have been helping customers transform their APIs into high-performance medicines for more than 60 years. For oral and parenteral drug delivery, Evonik combines market-leading portfolios of functional excipients with best-in-class formulation development and manufacturing services. We are also one of the world’s largest and most specialized CMOs for API, HPAPI and intermediates. Our global strength, expertise, and flexibility can help reduce project risk, accelerate the path to market, improve drug safety and efficacy, strengthen supply security, differentiate product brands, and improve patient compliance.

Oral Solid Dosage Forms

– With our EUDRAGIT® portfolio of functional polymers, Evonik provides pharmaceutical companies with unrivalled versatility to match any release profile for oral solid dosage forms. Being easy to handle, consistently manufactured to a high-quality standard, and compatible with all relevant process technologies, EUDRAGIT® polymers have a history of excellence for safety and performance that spans more than 60 years.

-Best-in-class formulation services and drug delivery technologies can be leveraged to protect the drug, improve targeting, and boost performance.

– With a global network of formulation and application experts, Evonik can reduce complexity from initial concept to final dosage form.

-Additional services include the clinical production and scale-up of oral solid dosage forms, and local regulatory support.

Specialized Parenterals

– Evonik is a global CDMO partner for specialized parenterals with strong backward integration in the design and production of excipients.

– RESOMER® is a broad portfolio of standard and custom bioresorbable polymers for parenteral controlled release with a proven track record for safety and supply security that spans more than three decades.

– As a global formulation and process development leader for polymeric microparticles, lipid nanoparticles, and implants, we provide advanced formulation solutions for systemic and local delivery across drug areas including siRNA, mRNA, oligonucleotides, peptides, and HPAPIs.

– In addition to project services from feasibility review through to clinical and commercial cGMP manufacturing, Evonik also provides aseptic filling services for powders, liquids, and suspensions.